ORIGINAL RESEARCH
Accepted on 04 Feb 2025
Enhanced Efficacy of Immune Checkpoint Inhibitors Combined Locoregional Therapy and Tyrosine Kinase Inhibitors in the Treatment of Unresectable Hepatocellular Carcinoma: A Single -Center Retrospective Study
doi 10.3389/fonc.2025.1554711